Twin Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Twin Capital Management's IDXX Position: Q1 2022 in Review
Twin Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 6,043 shares — an estimated $3.98M sold.
Twin Capital Management first reported a position in IDXX in Q4 2016 and held it in 20 quarters. The position peaked at $7.27M in Q2 2021. 1,031 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.
- Twin Capital Management reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
- Twin Capital Management sold 6,043 Idexx Laboratories shares in Q1 2022, an estimated $3.98M.
- Twin Capital Management first reported a position in Idexx Laboratories in Q4 2016 and held it in 20 quarters.
- Twin Capital Management's Idexx Laboratories position peaked at $7.27M in Q2 2021.
- 1,031 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.
Based on Twin Capital Management's 13F filing for Q1 2022, filed 6 May 2022.